Clinical Trial Update: Partial Thromboplastin Time After 72 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin [NA]

View source ↗

Summary

Completed clinical trial evaluating partial thromboplastin time after 72 hours of antithrombotic prophylaxis with unfractionated heparin in thrombosis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombosis

Drugs mentioned

• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Thrombosis | NA | Status: COMPLETED